Gene · 6510
Papers3,624
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,624
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The disruption of NEAT1-miR-125b-5p-SLC1A5 cascade defines the oncogenicity and differential immune profile in head and neck squamous cell carcinoma. | Cell Death Discov | 2024 | 39223142 | PubTator, text mining | PubMed |
| Epigenome-wide association study on the plasma metabolome suggests self-regulation of the glycine and serine pathway through DNA methylation. | Clin Epigenetics | 2024 | 39138531 | PubTator, text mining | PubMed |
| Methodological Approaches for Increasing the Retroviral Transduction Efficiency of Primary NK Cells. | Curr Pharm Des | 2024 | 39136515 | PubTator, text mining | PubMed |
| Integrated machine learning screened glutamine metabolism-associated biomarker SLC1A5 to predict immunotherapy response in hepatocellular carcinoma. | Immunobiology | 2024 | 39096658 | PubTator, text mining | PubMed |
| Structural basis of the obligatory exchange mode of human neutral amino acid transporter ASCT2. | Nat Commun | 2024 | 39095408 | Swiss-Prot, curated | PubMed |
| Impact of second autologous stem-cell transplantation at relapsed multiple myeloma: A French multicentric real-life study. | Hemasphere | 2024 | 39081803 | PubTator, text mining | PubMed |
| Hypoxia-induced cysteine metabolism reprogramming is crucial for the tumorigenesis of colorectal cancer. | Redox Biol | 2024 | 39079386 | PubTator, text mining | PubMed |
| Co-Expression Network Analysis and Molecular Docking Demonstrate That Diosgenin Inhibits Gastric Cancer Progression via SLC1A5/mTORC1 Pathway. | Drug Des Devel Ther | 2024 | 39071813 | PubTator, text mining | PubMed |
| ASCT2 is a major contributor to serine uptake in cancer cells. | Cell Rep | 2024 | 39068660 | PubTator, text mining | PubMed |
| Reprogramming of Glutamine Amino Acid Transporters Expression and Prognostic Significance in Hepatocellular Carcinoma. | Int J Mol Sci | 2024 | 39062801 | PubTator, text mining | PubMed |
| HMGA2-mediated glutamine metabolism is required for Cd-induced cell growth and cell migration. | Toxicology | 2024 | 39032683 | PubTator, text mining | PubMed |
| Overcoming Cancer Persister Cells by Stabilizing the ATF4 Promoter G-quadruplex. | Adv Sci (Weinh) | 2024 | 38994891 | PubTator, text mining | PubMed |
| Distinct roles and molecular mechanisms of nicotine and benzo(a)pyrene in ferroptosis of lung adenocarcinoma and lung squamous cell carcinoma. | Tob Induc Dis | 2024 | 38947555 | PubTator, text mining | PubMed |
| PoRVA G9P[23] and G5P[7] infections differentially promote PEDV replication by reprogramming glutamine metabolism. | PLoS Pathog | 2024 | 38905309 | PubTator, text mining | PubMed |
| Particulate matter facilitates amphiregulin-dependent lung cancer proliferation through glutamine metabolism. | Int J Biol Sci | 2024 | 38904011 | PubTator, text mining | PubMed |
| How Much Do You Fuse? A Comparison of Cell Fusion Assays in a Breast Cancer Model. | Int J Mol Sci | 2024 | 38891857 | PubTator, text mining | PubMed |
| Claudin-4 Modulates Autophagy via SLC1A5/LAT1 as a Mechanism to Regulate Micronuclei. | Cancer Res Commun | 2024 | 38867360 | PubTator, text mining | PubMed |
| The tRNA Gm18 methyltransferase TARBP1 promotes hepatocellular carcinoma progression via metabolic reprogramming of glutamine. | Cell Death Differ | 2024 | 38867004 | PubTator, text mining | PubMed |
| ATF4 as a Prognostic Marker and Modulator of Glutamine Metabolism in Oestrogen Receptor-Positive Breast Cancer. | Pathobiology | 2024 | 38861938 | PubTator, text mining | PubMed |
| Elevated SLC1A5 associated with poor prognosis and therapeutic resistance to transarterial chemoembolization in hepatocellular carcinoma. | J Transl Med | 2024 | 38844930 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6510/papers?page=13